Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence
| Errataetall: |
CommentOn: Travel Med Infect Dis. 2020 May - Jun;35:101738. - PMID 32387409 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Travel medicine and infectious disease - 38(2020) vom: 20. Nov., Seite 101886 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bigna, Jean Joel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4QWG6N8QKH |
|---|
| Anmerkungen: |
Date Completed 30.12.2020 Date Revised 10.01.2021 published: Print-Electronic CommentOn: Travel Med Infect Dis. 2020 May - Jun;35:101738. - PMID 32387409 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.tmaid.2020.101886 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315512652 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315512652 | ||
| 003 | DE-627 | ||
| 005 | 20231225155058.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.tmaid.2020.101886 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1051.xml |
| 035 | |a (DE-627)NLM315512652 | ||
| 035 | |a (NLM)32980540 | ||
| 035 | |a (PII)S1477-8939(20)30382-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bigna, Jean Joel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.12.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Travel Med Infect Dis. 2020 May - Jun;35:101738. - PMID 32387409 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 650 | 7 | |a Azithromycin |2 NLM | |
| 650 | 7 | |a 83905-01-5 |2 NLM | |
| 700 | 1 | |a Kamtchum-Tatuene, Joseph |e verfasserin |4 aut | |
| 700 | 1 | |a Noubiap, Jean Jacques |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Travel medicine and infectious disease |d 2003 |g 38(2020) vom: 20. Nov., Seite 101886 |w (DE-627)NLM16457655X |x 1873-0442 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2020 |g day:20 |g month:11 |g pages:101886 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.tmaid.2020.101886 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2020 |b 20 |c 11 |h 101886 | ||